Pharmaceutical News

RSS

Ticagrelor drug may reduce risk of dying following heart attack

Scientists from the University of Sheffield have discovered ground breaking clues as to how the pioneering heart drug ticagrelor might reduce the risk of dying following a heart attack, in comparison to previous standard treatments.

16 Oct 2013

Pieris, Zydus Cadila partner to develop and commercialize Anticalin-based protein therapeutics

Zydus Cadila, an innovative global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare products, and Pieris AG, a next generation therapeutic protein R&D company, have entered into an alliance for development and commercialization of multiple novel Anticalin-based protein therapeutics, both companies announced today.

16 Oct 2013

Pregnant women exposed to metoclopramide experience no increased risk of congenital malformations

In an analysis that included more than 40,000 women exposed to the nausea medication metoclopramide in pregnancy, use of this drug was not associated with significantly increased risk of major congenital malformations overall, spontaneous abortion, and stillbirth, according to a study in the October 16 issue of JAMA.

16 Oct 2013

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Janssen-Cilag International NV, today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency seeking approval for a once-daily single tablet fixed-dose antiretroviral combination product containing darunavir, a protease inhibitor developed by Janssen, with cobicistat, a pharmacokinetic enhancer or boosting agent, developed by Gilead Sciences, Inc. for use in combination with other human immunodeficiency virus medicines.

15 Oct 2013

Study explores why girls in minority groups, low-income families don't get HPV vaccine

A new study explores why girls in minority groups and low-income families, who are most at risk for cervical cancer, may not be getting the human papillomavirus or HPV vaccine.

15 Oct 2013

Marketing and technical support cooperation for aqueous acrylic enteric system, Acryl-EZE®, launched by Colorcon and Evonik Industries

Colorcon Inc. and Evonik Industries AG have announced the signing of a cooperation agreement for the marketing and technical support of Acryl-EZE®, aqueous acrylic enteric system.

15 Oct 2013

Researchers to present latest findings in emergency medicine research at ACEP13-Scientific Assembly

Leading researchers in emergency medicine will present more than 400 studies during ACEP13-Scientific Assembly, the annual meeting of the American College of Emergency Physicians in Seattle, Washington.

15 Oct 2013

Measles-containing vaccines administered at 12-5 months of age associated with reduced risk of fever, seizures

Children receiving measles-containing vaccines at 12-15 months of age have a lower increased risk of fever and seizures than those who receive them at 16-23 months of age, according to a new Kaiser Permanente study published in JAMA Pediatrics.

15 Oct 2013

Scientists identify dangerous amount of methamphetamine analog in workout supplement Craze

An international team of scientists have identified potentially dangerous amounts of methamphetamine analog in the workout supplement Craze, a product widely sold across the U.S. and online.

15 Oct 2013

NICE issues second draft guidance on PIXUVRI for treatment of aggressive B-cell NHL

Cell Therapeutics, Inc. today announced that the National Institute for Health and Care Excellence, a non-departmental public body of the Department of Health in the United Kingdom, issued second draft guidance on PIXUVRI (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.

15 Oct 2013

Study: Non-hallucinogenic components of cannabis may act as effective anti-cancer agents

The anti-cancer properties of tetrahydrocannabinol (THC), the primary hallucinogenic component of cannabis, has been recognised for many years, but research into similar cannabis-derived compounds, known as cannabinoids, has been limited.

15 Oct 2013

High doses of ADHD drugs may be effective for people with amphetamine dependency

People with ADHD and dependency rarely respond as they should to ADHD drugs. A randomised study from Karolinska Institutet in Sweden now shows that it is possible to obtain the desired efficacy by administering the drug in higher doses.

15 Oct 2013

Teva gets FDA approval for generic version of TOBI in US

Teva Pharmaceutical Industries Ltd. announces today that the U.S. Food and Drug Administration has granted approval of the generic equivalent to TOBI (Tobramycin Inhalation Solution USP) in the United States.

15 Oct 2013

FDA approves OTREXUP injection for adults with RA, children with active pJIA

Antares Pharma, Inc. today announced the approval of OTREXUP (methotrexate) injection by the U.S. Food and Drug Administration. OTREXUP is the first FDA approved subcutaneous methotrexate for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.

14 Oct 2013

Statins may increase risk of cataracts among individuals above 30 years old

According to the Centers for Disease Control and Prevention, cataracts are the number one cause of vision loss in the United States. Nearly 22 million Americans age 40 and over have cataracts, while more than half of individuals age 80 and over suffer from this condition. In a recent study released in JAMA Ophthalmology, it was confirmed that statins, which are typically prescribed to reduce cholesterol and also prevent heart disease, may cause an increased risk for cataracts among individuals ages 30 through 85.

14 Oct 2013

Blood test can help predict which bipolar patients will benefit from Ketamine

Researchers have discovered how to determine which bipolar patients will benefit from Ketamine, a treatment commonly used for depression and pain relief, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.

14 Oct 2013

BioInvent extends license agreement with Bayer to develop antibodies

BioInvent International AB today announces that it has signed an extension to its 2008 license agreement with Bayer Pharma AG for the development of antibodies from BioInvent's n-CoDeR libraries.

14 Oct 2013

Pregabalin drug can help reduce incidence of chronic pain following cardiac surgery

The incidence of chronic pain following cardiac surgery can be reduced in patients when the drug pregabalin is used before surgery and for 14 days post-surgery, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.

14 Oct 2013

Multi-drug therapy can benefit patients at higher risk for post-operative nausea and vomiting

Ninety-seven percent of bariatric surgery patients avoided post-operative nausea and vomiting with the addition of a second drug to the standard treatment given during surgery, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.

14 Oct 2013

ASA launches Opioid Overdose Resuscitation card to help people who abuse prescription drugs

In response to the prescription drug abuse epidemic in the United States, the American Society of Anesthesiologists is collaborating with the White House Office of National Drug Control Policy to respond to the problem, educate the public and advance programs to help those who misuse and abuse prescription drugs.

14 Oct 2013

Pharmaceutical News

Ticagrelor drug may reduce risk of dying following heart attack

Pieris, Zydus Cadila partner to develop and commercialize Anticalin-based protein therapeutics

Pregnant women exposed to metoclopramide experience no increased risk of congenital malformations

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Study explores why girls in minority groups, low-income families don't get HPV vaccine

Marketing and technical support cooperation for aqueous acrylic enteric system, Acryl-EZE®, launched by Colorcon and Evonik Industries

Researchers to present latest findings in emergency medicine research at ACEP13-Scientific Assembly

Measles-containing vaccines administered at 12-5 months of age associated with reduced risk of fever, seizures

Scientists identify dangerous amount of methamphetamine analog in workout supplement Craze

NICE issues second draft guidance on PIXUVRI for treatment of aggressive B-cell NHL

Study: Non-hallucinogenic components of cannabis may act as effective anti-cancer agents

High doses of ADHD drugs may be effective for people with amphetamine dependency

Teva gets FDA approval for generic version of TOBI in US

FDA approves OTREXUP injection for adults with RA, children with active pJIA

Statins may increase risk of cataracts among individuals above 30 years old

Blood test can help predict which bipolar patients will benefit from Ketamine

BioInvent extends license agreement with Bayer to develop antibodies

Pregabalin drug can help reduce incidence of chronic pain following cardiac surgery

Multi-drug therapy can benefit patients at higher risk for post-operative nausea and vomiting

ASA launches Opioid Overdose Resuscitation card to help people who abuse prescription drugs

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News